Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page shows updated study record dates, including the last update and results posting dates. Core study details such as completion status and locations appear current.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating status details for the NIH Clinical Center, plus a link to relevant official sites. - Upgraded version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T05:59:49.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page updates its metadata to reflect a newer version (v3.1.0) and more recent dates (September 2025), while removing older metadata (v3.0.2 and May 2025 dates).
    Difference
    0.7%
    Check dated 2025-09-29T03:14:39.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' control was removed. No substantive changes to core content, pricing, names, stock, or time slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T20:12:54.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T17:05:54.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to digestive diseases and proteins. However, several previous entries, including specific cancer-related terms and immunological agents, have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:09:10.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.